| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/18/2005 | WO2005001096A8 Vaccines against sars |
| 08/18/2005 | WO2004110387A3 Sigma ligands for neuronal regeneration and functional recovery |
| 08/18/2005 | WO2004103159A3 Methods for modulating endometrium |
| 08/18/2005 | WO2004091490A3 Somatostatin-dopamine chimeric analogs |
| 08/18/2005 | WO2004085469A3 Secreted protein family |
| 08/18/2005 | WO2004084821A3 Hemipteran glutamate decarboxylase |
| 08/18/2005 | WO2004083365A3 Compounds and their use for specific and simultaneous inhibition of genes involved in diseases and related drugs |
| 08/18/2005 | WO2004058949A3 Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof |
| 08/18/2005 | WO2004054516A3 Antagonists for human prolactin |
| 08/18/2005 | WO2004045519A3 Induction of apoptosis by hiv-1 infected monocytic cells |
| 08/18/2005 | WO2004035729A3 Esterases, nucleic acids encoding them and methods of making and using them |
| 08/18/2005 | WO2003072601A8 Method for producing hypoallergenic major birch pollen allergens rbet v 1 |
| 08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
| 08/18/2005 | US20050183148 Lymphocyte surface receptor that binds caml and methods of use thereof |
| 08/18/2005 | US20050183146 Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule |
| 08/18/2005 | US20050183144 Gab1 involvement in glucose homeostasis regulation by hepatocytes |
| 08/18/2005 | US20050182496 Soft tissue implants and anti-scarring agents |
| 08/18/2005 | US20050182469 Electrical devices and anti-scarring agents |
| 08/18/2005 | US20050182468 Electrical devices and anti-scarring agents |
| 08/18/2005 | US20050182467 Electrical devices and anti-scarring agents |
| 08/18/2005 | US20050182463 Polymer compositions and methods for their use |
| 08/18/2005 | US20050182450 Electrical devices and anti-scarring agents |
| 08/18/2005 | US20050182418 Devices and methods for the restoration of a spinal disc |
| 08/18/2005 | US20050182245 Novel receptors |
| 08/18/2005 | US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 08/18/2005 | US20050182047 Treatment of demyelinating disorders |
| 08/18/2005 | US20050182046 Alzheimer's disease; 3-(S)-(N'-(3,5-difluorophenylacetyl)-L-alaninyl)amino-1-benzyl- epsilon -caprolactam; 4-(N'-(3,5-Difluorophenylacetyl)-L-alaninyl)amino-1-(pyrid-4-yl)-71,2,3,4-tetrahydroisoquinolin-3-one |
| 08/18/2005 | US20050182015 Antisense modulation of EIF2C1 expression |
| 08/18/2005 | US20050182014 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (GHRH) supplementation |
| 08/18/2005 | US20050182013 mixing oligonucleotide and a polymer to form complex wherein zeta potential of complex is not positive, inserting oligonucleotide into mammalian blood vessel in vivo, increasing permeability of blood vessel, passing complex through vessel |
| 08/18/2005 | US20050182011 Use inhibitors of Transient Receptor Potential (TRP) channels to block non-voltage gated calcium flux into cells |
| 08/18/2005 | US20050182009 siNA molecule comprising a double-stranded structure that down-regulates expression of NF-Kappa B / REL-A , wherein said siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 08/18/2005 | US20050182008 chemically synthesized double stranded siNA; NOGO genes encode potent inhibitors of neurite outgrowth; treating various nervous system disorders such as brain or spinal cord injury, cerebrovascular disorders, Alzheimer's disease, dementia, and neurodegenerative disorders |
| 08/18/2005 | US20050182007 siNA molecule comprising a double-stranded structure that down-regulates expression of interleukin and interleukin receptor , wherein said siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 08/18/2005 | US20050182006 Cancer and proliferative diseases |
| 08/18/2005 | US20050181998 Prion inhibiting peptides and derivatives thereof |
| 08/18/2005 | US20050181996 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 08/18/2005 | US20050181995 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof |
| 08/18/2005 | US20050181994 Soluble, recombinant CD40L variant proteins that may be expressed solubly in E. coli |
| 08/18/2005 | US20050181993 Method for using lipoprotein associated coagulation inhibitor to treat sepsis |
| 08/18/2005 | US20050181992 Isolated from the submaxiliary saliva glands of shrews; calcium channel blocker, analgesic, insecticide |
| 08/18/2005 | US20050181991 Use of artemin, a member of the GDNF ligand family |
| 08/18/2005 | US20050181990 Administered before,during or after chemotherapy |
| 08/18/2005 | US20050181988 antifungal, inhibitory activity on beta -1,3-glucan synthase, treatment of Pneumocystis carinii infection |
| 08/18/2005 | US20050181987 Compositions and methods for treatment of cancer |
| 08/18/2005 | US20050181986 Method of treating disturbances of iron distribution in inflammatory intestinal diseases |
| 08/18/2005 | US20050181985 Coupling proteins to a modified polysaccharide |
| 08/18/2005 | US20050181984 Acyl derivatives of the echinocandin; aerosol spray; Pneumocystis carinii |
| 08/18/2005 | US20050181983 Treatment of shock using adrenomedullin binding protein-1 |
| 08/18/2005 | US20050181981 Method of treatment |
| 08/18/2005 | US20050181979 Vascular endothelial growth factor-2 |
| 08/18/2005 | US20050181978 for treating bleeding episodes, result in reduced clotting time, enhancement of hemostasis, increase in clot lysis time, increase in clot strength and/or increase in overall clot quality |
| 08/18/2005 | US20050181977 Medical implants and anti-scarring agents |
| 08/18/2005 | US20050181976 coupled to therapeutic proteins or peptides; biochemical conjugation |
| 08/18/2005 | US20050181974 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
| 08/18/2005 | US20050181973 comprising alternating hydrophobic and hydrophilic amino acids that are complementary and structurally compatible; three-dimensional scaffolds, encapsulating cells, used for cell cultures, tissue engineering and tissue repair |
| 08/18/2005 | US20050181972 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 08/18/2005 | US20050181971 Treatment of type i diabetes mellitus |
| 08/18/2005 | US20050181516 Bioequivalence determination using expression profiling |
| 08/18/2005 | US20050181500 A recombinant expression vector; an isolated nucleic acid molecule; diagnosis of high blood pressure, obesity |
| 08/18/2005 | US20050181476 Novel splice variant of MyD88 and uses thereof |
| 08/18/2005 | US20050181474 Transport peptides and uses therefor |
| 08/18/2005 | US20050181471 artificial polynucleotide for incorporating an unnatural amino acid into a protein and attaching one or more saccharide moieties to the unnatural amino acid; mimetics; expression vector; kits |
| 08/18/2005 | US20050181458 Bioassay for measuring the proliferation of T-cells in Human papiloma virus |
| 08/18/2005 | US20050181457 Mixture comprising immunogllobulin G complex for diagnosis, prevention and treatment of autoimmune and allergic disorders |
| 08/18/2005 | US20050181444 related to the Pftaire kinase subfamily; gene chip; transgenic nonhuman animal; nucleic acid vector; models for human therapeutic targets; expression in humans in uterus endometrium adenocarcinoma, testis, lung fibroblasts, kidney renal cell adenocarcinoma, and the brain |
| 08/18/2005 | US20050181442 HCaRG, a novel calcium-regulated gene coding for a nuclear protein |
| 08/18/2005 | US20050181439 Streptococcus pneumoniae antigens and vaccines |
| 08/18/2005 | US20050181438 Nucleotide sequences coding monocarboxylate (MCT) transport protein for identifying modulators to treat hyperlysinemia; rational drug design and screening |
| 08/18/2005 | US20050181427 Peptide nucleic acid probes for identifying gene sequences associated with ion transport; fish farms and breeding |
| 08/18/2005 | US20050181426 Peptide nucleic acid probes for identifying gene sequences associated with ion transport; fish farms and breeding |
| 08/18/2005 | US20050181425 Polyvalent cation-sensing receptor in atlantic salmon |
| 08/18/2005 | US20050181420 Polypeptide that interacts with heat shock proteins |
| 08/18/2005 | US20050181419 For detection of Mycobacterium tuberculosis infection |
| 08/18/2005 | US20050181415 Drug metabolizing enzymes |
| 08/18/2005 | US20050181404 Proteolytic enzyme for use as tool in identifying modulators for prevention and treatment of cell proliferative and immune disorders |
| 08/18/2005 | US20050181402 Immunoglobulin which specifically binds serum and glucocorticoid dependent kinase for diagnosing infection, inflammatory, kidney and liver disorders |
| 08/18/2005 | US20050181376 Antisense modulation of microsomal triglyceride transfer protein expression |
| 08/18/2005 | US20050181372 Interleukin 17 receptor-like protein |
| 08/18/2005 | US20050181368 Protein for use in hypoxia related conditions |
| 08/18/2005 | US20050181066 Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency |
| 08/18/2005 | US20050181064 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith |
| 08/18/2005 | US20050181059 Mixing a nonsolvent (tert-butyl alcohol) that is miscible with water with the aqueous solution and precipitating particles of the biologically active agents out of the nonsolvent |
| 08/18/2005 | US20050181054 comprising a water-insoluble and/or water-low soluble substance, a medicament, and an aqueous medium, and having an osmotic pressure of less than 290 mOsm; efficient penetration and high permeability blood at the mucosa |
| 08/18/2005 | US20050181046 Tamper-resistant oral opioid agonist formulations |
| 08/18/2005 | US20050181041 Forming solution of drugs, dietary supplements, and/or agrochemicals and crystal lattice modifier dissolved in a solvent; mixing with nonsolvent; crystallization; drug delivery; stability |
| 08/18/2005 | US20050181037 Cardiolipin compositions their methods of preparation and use |
| 08/18/2005 | US20050181018 Ocular drug delivery |
| 08/18/2005 | US20050181011 Medical implants and anti-scarring agents |
| 08/18/2005 | US20050181010 Breast, pectoral, chin, facial, lip, and nasal implants; inhibits angiogenesis and fibroblast migration; enzyme inhibitors; glucose monitor |
| 08/18/2005 | US20050181009 Breast, pectoral, chin, facial, lip, and nasal implants; inhibits angiogenesis and fibroblast migration; enzyme inhibitors |
| 08/18/2005 | US20050181008 Implant provides a surgical adhesion barrier and is coated with an antifibrotic agent, such as a cell cycle inhibitor, and an optional antibiotic |
| 08/18/2005 | US20050181007 To inhibit scarring when the implant is placed within an animal; breast impant for reconstruction or cosmetic implants; antiscarring agent can be a taxane |
| 08/18/2005 | US20050181005 Breast, pectoral, chin, facial, lip, and nasal implants; inhibits angiogenesis and fibroblast migration; enzyme inhibitors |
| 08/18/2005 | US20050181004 Intravascular devices and fibrosis-inducing agents |
| 08/18/2005 | US20050180996 Vaccine composition specific to glyceroaldehyde-3-phosphate dehydrogenase for use as tool in prevention and treatment of coccidiosis; veterinary medicine |
| 08/18/2005 | US20050180995 Method to Improve Grafted Hair Growth And Retain Grafted Hair |
| 08/18/2005 | US20050180982 Assessing metastatic potential of carcinoma cells by contacting cells in tissue sample suspected of containing carcinoma with detectable indicator capable of binding to cad-11 or cad-11 mRNA and determining presence or absence of cad-11 expression in tissue; method of preventing or terminating pregnancy |
| 08/18/2005 | US20050180981 Human checkpoint kinase, hCDS1, compositions and methods |
| 08/18/2005 | US20050180980 Novel antibody recognizing a small subset of human hematopoietic cells |